GB1445595A
(en)
|
1973-09-06 |
1976-08-11 |
Wyeth John & Brother Ltd |
4-aminoquinoline derivatives and intermediates for their pre paration
|
US4131680A
(en)
|
1974-12-11 |
1978-12-26 |
John Wyeth & Brother Ltd. |
Hypotensive sulphonamidopiperidyl indoles
|
GB1482099A
(en)
*
|
1974-12-11 |
1977-08-03 |
Wyeth John & Brother Ltd |
Sulphonamido derivatives
|
DE2718405A1
(de)
|
1977-04-26 |
1978-11-02 |
Boehringer Sohn Ingelheim |
Neue n- eckige klammer auf 1-(3-benzoylpropyl)-4-piperidyl eckige klammer zu -sulfonsaeureamide und verfahren zu deren herstellung
|
IN148482B
(zh)
|
1977-06-03 |
1981-03-07 |
Pfizer |
|
JP2641070B2
(ja)
|
1988-12-06 |
1997-08-13 |
富士写真フイルム株式会社 |
ハロゲン化銀カラー写真感光材料
|
US4990523A
(en)
|
1989-06-19 |
1991-02-05 |
A. H. Robins Company, Incorporated |
Treatment of chronic inflammatory joint disease with arylsulfonamides
|
JPH05201971A
(ja)
|
1992-01-28 |
1993-08-10 |
Hokuriku Seiyaku Co Ltd |
環状アミン含有ベンゼンスルホンアミド誘導体
|
US5177217A
(en)
|
1992-04-27 |
1993-01-05 |
Warner-Lambert Company |
Process for the manufacture of (S)-3-amino-1-substituted-pyrrolidines
|
US5723490A
(en)
|
1992-09-08 |
1998-03-03 |
Vertex Pharmaceuticals Incorporated |
THF-containing sulfonamide inhibitors of aspartyl protease
|
US5739135A
(en)
|
1993-09-03 |
1998-04-14 |
Bristol-Myers Squibb Company |
Inhibitors of microsomal triglyceride transfer protein and method
|
IL115420A0
(en)
|
1994-09-26 |
1995-12-31 |
Zeneca Ltd |
Aminoheterocyclic derivatives
|
TW406075B
(en)
|
1994-12-13 |
2000-09-21 |
Upjohn Co |
Alkyl substituted piperidinyl and piperazinyl anti-AIDS compounds
|
US5688960A
(en)
|
1995-05-02 |
1997-11-18 |
Schering Corporation |
Substituted oximes, hydrazones and olefins useful as neurokinin antagonists
|
US5696267A
(en)
|
1995-05-02 |
1997-12-09 |
Schering Corporation |
Substituted oximes, hydrazones and olefins as neurokinin antagonists
|
EP0828754B1
(en)
|
1995-05-29 |
2005-02-02 |
Pfizer Inc. |
Dipeptides which promote release of growth hormone
|
EP0833622B8
(en)
|
1995-06-12 |
2005-10-12 |
G.D. Searle & Co. |
Compositions comprising a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor
|
IL123430A
(en)
|
1995-10-05 |
2001-04-30 |
Darwin Discovery Ltd |
Theo-converted peptides as inhibitors for metallic proteinases and TNF release
|
US6124341A
(en)
|
1996-02-13 |
2000-09-26 |
Abbott Laboratories |
Endothelin antagonists
|
US5827875A
(en)
|
1996-05-10 |
1998-10-27 |
Bristol-Myers Squibb Company |
Inhibitors of microsomal triglyceride transfer protein and method
|
WO1997045119A1
(en)
|
1996-05-24 |
1997-12-04 |
Novartis Ag |
Use of substance p antagonists for treating social phobia
|
US20020128476A1
(en)
|
1996-08-08 |
2002-09-12 |
Smithkline Beecham Corporation |
Inhibitors of cysteine protease
|
US6281227B1
(en)
|
1996-12-13 |
2001-08-28 |
Aventis Pharma Deutschland Gmbh |
Sulfonic acid sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds
|
US5972963A
(en)
|
1996-12-23 |
1999-10-26 |
Hoechst Marion Roussel, Inc. |
3-aryl-2-(1-substituted 4-piperidinyl)-1,1-dioxo-3H-benzo[D]isothiazoles and related compounds
|
US6376506B1
(en)
|
1997-01-23 |
2002-04-23 |
Syntex (U.S.A.) Llc |
Sulfamide-metalloprotease inhibitors
|
ZA98376B
(en)
|
1997-01-23 |
1998-07-23 |
Hoffmann La Roche |
Sulfamide-metalloprotease inhibitors
|
GB9714129D0
(en)
|
1997-07-04 |
1997-09-10 |
Pfizer Ltd |
Azetidines
|
US6136827A
(en)
|
1997-07-25 |
2000-10-24 |
Merck & Co., Inc. |
Cyclic amine modulations of chemokine receptor activity
|
US6525042B1
(en)
|
1997-09-30 |
2003-02-25 |
Daiichi Pharmaceutical Co., Ltd. |
Sulfonyl derivatives
|
US6130220A
(en)
|
1997-10-16 |
2000-10-10 |
Syntex (Usa) Inc. |
Sulfamide-metalloprotease inhibitors
|
US6750228B1
(en)
|
1997-11-14 |
2004-06-15 |
Pharmacia Corporation |
Aromatic sulfone hydroxamic acid metalloprotease inhibitor
|
JP4676613B2
(ja)
|
1998-01-27 |
2011-04-27 |
アベンティス・ファーマスーティカルズ・インコーポレイテツド |
置換オキソアザヘテロシクリルXa因子阻害剤
|
PL343435A1
(en)
|
1998-03-06 |
2001-08-13 |
Janssen Pharmaceutica Nv |
Glycine transport inhibitors
|
GB9805520D0
(en)
|
1998-03-17 |
1998-05-13 |
Zeneca Ltd |
Chemical compounds
|
US6384080B1
(en)
|
1998-04-20 |
2002-05-07 |
Fujisawa Pharmaceutical Co., Ltd. |
Anthranilic acid derivatives as inhibitors of the cGMP-phosphodiesterase
|
US6303620B1
(en)
|
1998-05-11 |
2001-10-16 |
Novo Nordisk A/S |
Compounds with growth hormone releasing properties
|
US6492375B2
(en)
|
1998-06-30 |
2002-12-10 |
Neuromed Technologies, Inc. |
Partially saturated calcium channel blockers
|
US6387897B1
(en)
|
1998-06-30 |
2002-05-14 |
Neuromed Technologies, Inc. |
Preferentially substituted calcium channel blockers
|
US6310059B1
(en)
|
1998-06-30 |
2001-10-30 |
Neuromed Technologies, Inc. |
Fused ring calcium channel blockers
|
US6011035A
(en)
|
1998-06-30 |
2000-01-04 |
Neuromed Technologies Inc. |
Calcium channel blockers
|
US6423519B1
(en)
|
1998-07-15 |
2002-07-23 |
Gpc Biotech Inc. |
Compositions and methods for inhibiting fungal growth
|
US6316623B1
(en)
|
1998-08-21 |
2001-11-13 |
Isis Pharmaceuticals, Inc. |
Ethylenediamine compound libraries
|
HUP0100819A3
(en)
|
1998-10-16 |
2002-12-28 |
Daiichi Asubio Pharma Co Ltd |
Aminophenoxyacetic acid derivatives as neuroprotectants and pharmaceutical compositions containing them
|
US6267945B1
(en)
|
1998-12-18 |
2001-07-31 |
Neuromed Technologies, Inc. |
Farnesol-related calcium channel blockers
|
US6248739B1
(en)
|
1999-01-08 |
2001-06-19 |
Pharmacia & Upjohn Company |
Quinolinecarboxamides as antiviral agents
|
AUPP818099A0
(en)
|
1999-01-14 |
1999-02-11 |
Fujisawa Pharmaceutical Co., Ltd. |
New n-containing heterocyclic compounds
|
US6841552B1
(en)
|
1999-05-05 |
2005-01-11 |
Ortho-Mcneil Pharmaceutical, Inc. |
3a,4,5,9b-tetrahydro-1H-benz[e]indol-2-yl amine-derived neuropeptide Y receptors ligands useful in the treatment of obesity and other disorders
|
WO2001024786A1
(fr)
|
1999-05-13 |
2001-04-12 |
Shionogi & Co., Ltd. |
Principes actifs destines au soin ou a la prevention de diabetes
|
US6344358B1
(en)
|
1999-05-28 |
2002-02-05 |
Fujisawa Pharmaceutical Co., Ltd. |
Agent for expression of long-term potentiation of synaptic transmission comprising compound having brain somatostatin activation property
|
CA2377369A1
(en)
|
1999-06-04 |
2000-12-14 |
Merck & Co., Inc. |
Substituted piperidines as melanocortin-4 receptor agonists
|
GB2352240A
(en)
|
1999-07-13 |
2001-01-24 |
Lilly Co Eli |
Novel sulphonamides useful in treating CNS disorders
|
DE60023148T2
(de)
|
1999-07-28 |
2006-07-06 |
Ortho-Mcneil Pharmaceutical, Inc. |
Amine and amide als ligande für den neuropeptid-y y5 rezeptor, und ihre anwendung zur behandlung von fettleibigkeit und anderen erkrankungen
|
US20020151712A1
(en)
|
1999-09-14 |
2002-10-17 |
Nan-Horng Lin |
3-pyrrolidinyloxy-3'-pyridyl ether compounds useful for controlling chemical synaptic transmission
|
PE20010628A1
(es)
|
1999-10-01 |
2001-06-18 |
Takeda Chemical Industries Ltd |
Compuestos de amina ciclica, su produccion y su uso
|
EP1249233B9
(en)
|
1999-11-26 |
2009-08-05 |
Shionogi & Co., Ltd. |
Npyy5 antagonists
|
FR2802206B1
(fr)
|
1999-12-14 |
2005-04-22 |
Sod Conseils Rech Applic |
Derives de 4-aminopiperidine et leur utilisation en tant que medicament
|
CA2393825A1
(en)
|
1999-12-17 |
2001-06-21 |
Versicor, Inc. |
Novel succinate compounds, compositions and methods of use and preparation
|
US6797820B2
(en)
|
1999-12-17 |
2004-09-28 |
Vicuron Pharmaceuticals Inc. |
Succinate compounds, compositions and methods of use and preparation
|
FR2804429B1
(fr)
|
2000-01-31 |
2003-05-09 |
Adir |
Nouveaux derives de 4-sulfonamides piperidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
EP1254895B1
(en)
|
2000-01-20 |
2007-05-23 |
Eisai R&D Management Co., Ltd. |
Nitrogenous cyclic compounds and pharmaceutical compositions containing the same
|
US6566356B2
(en)
|
2000-03-03 |
2003-05-20 |
Aventis Pharma S.A. |
Pharmaceutical compositions containing 3-aminoazetidine derivatives, novel derivatives and their preparation
|
US6355631B1
(en)
|
2000-03-03 |
2002-03-12 |
Aventis Pharma S.A. |
Pharmaceutical compositions containing azetidine derivatives, novel azetidine derivatives and their preparation
|
AU4929601A
(en)
|
2000-03-23 |
2001-10-03 |
Merck & Co Inc |
Substituted piperidines as melanocortin receptor agonists
|
WO2001081308A2
(en)
|
2000-04-20 |
2001-11-01 |
Nps Allelix Corp. |
Aminopiperidines for use as glyt-1 inhibitors
|
JP2001322977A
(ja)
|
2000-05-12 |
2001-11-20 |
Kotobuki Seiyaku Kk |
ピペコリン酸誘導体及びその製造方法並びにこれを含有する医薬組成物
|
US6683093B2
(en)
|
2000-05-12 |
2004-01-27 |
Pharmacia Corporation |
Aromatic sulfone hydroxamic acids and their use as protease inhibitors
|
GB0011838D0
(en)
*
|
2000-05-17 |
2000-07-05 |
Astrazeneca Ab |
Chemical compounds
|
EP1162194A1
(en)
|
2000-06-06 |
2001-12-12 |
Aventis Pharma Deutschland GmbH |
Factor VIIa inhibitory (thio)urea derivatives, their preparation and their use
|
CN1245974C
(zh)
|
2000-06-28 |
2006-03-22 |
特瓦制药工业有限公司 |
卡维地洛
|
US6962917B2
(en)
|
2000-07-26 |
2005-11-08 |
Smithkline Beecham P.L.C. |
Aminopiperidine quinolines and their azaisosteric analogues with antibacterical activity
|
US20020055457A1
(en)
|
2000-08-07 |
2002-05-09 |
Janus Todd J. |
Methods of treating cancer and the pain associated therewith using endothelin antagonists
|
US20020165223A1
(en)
|
2000-09-14 |
2002-11-07 |
Greenlee William J. |
Substituted urea neuropeptide Y Y5 receptor antagonists
|
US6894063B2
(en)
|
2000-09-14 |
2005-05-17 |
Schering Corporation |
Substituted urea neuropeptide Y Y5 Receptor antagonists
|
WO2002024649A1
(en)
|
2000-09-25 |
2002-03-28 |
Actelion Pharmaceuticals Ltd |
Substituted amino-aza-cycloalkanes useful against malaria
|
US20020091114A1
(en)
|
2000-10-04 |
2002-07-11 |
Odile Piot-Grosjean |
Combination of a CB1 receptor antagonist and of sibutramine, the pharmaceutical compositions comprising them and their use in the treatment of obesity
|
US20020094989A1
(en)
|
2000-10-11 |
2002-07-18 |
Hale Jeffrey J. |
Pyrrolidine modulators of CCR5 chemokine receptor activity
|
DE10058461A1
(de)
|
2000-11-24 |
2002-09-19 |
Bayer Ag |
Substituierte Cyclohexanderivate und ihre Verwendung
|
IT1320862B1
(it)
|
2000-12-19 |
2003-12-10 |
Bottero Spa |
Convogliatore a tapparelle per l'avanzamento di lastre di vetro in unamacchina di molatura e macchina di molatura comprendente tale
|
US6946476B2
(en)
|
2000-12-21 |
2005-09-20 |
Schering Corporation |
Heteroaryl urea neuropeptide Y Y5 receptor antagonists
|
AU3405602A
(en)
|
2000-12-21 |
2002-07-01 |
Schering Corp |
Heteroaryl urea neuropeptide y y5 receptor antagonists
|
GB0101577D0
(en)
|
2001-01-22 |
2001-03-07 |
Smithkline Beecham Plc |
Compounds
|
DE60219295T2
(de)
|
2001-02-28 |
2008-01-03 |
Merck & Co., Inc. |
Acylierte piperidinderivate als melanocortin-4-rezeptoragonisten
|
US20040110952A1
(en)
|
2001-03-01 |
2004-06-10 |
Jeremy Burrows |
N-4-piperidinyl compounds as ccr5 modulators
|
WO2002079146A2
(en)
|
2001-03-02 |
2002-10-10 |
Bristol-Myers Squibb Company |
Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
|
WO2002079155A1
(en)
|
2001-03-29 |
2002-10-10 |
Smithkline Beecham Corporation |
Pyrrolidine sulfonamides
|
EP1253723A1
(en)
*
|
2001-04-23 |
2002-10-30 |
Lucent Technologies Inc. |
Transmitter/receiver device with re-configurable output combining
|
JP3834485B2
(ja)
|
2001-05-28 |
2006-10-18 |
株式会社日立製作所 |
レーザ駆動装置とそれを用いた光ディスク装置、及びそのレーザ制御方法
|
US7067507B2
(en)
|
2001-06-12 |
2006-06-27 |
Pharmacia & Upjohn Company |
Macrocycles useful in the treatment of Alzheimer's disease
|
ES2296979T3
(es)
|
2001-06-27 |
2008-05-01 |
Smithkline Beecham Corporation |
Fluoropirrolidinas como inhibidores de dipeptidil peptidasa.
|
US20030006081A1
(en)
|
2001-07-03 |
2003-01-09 |
David Burke |
Drive train and steering method and apparatus for race trucks
|
CN1911913A
(zh)
|
2001-07-26 |
2007-02-14 |
先灵公司 |
取代脲类神经肽y y5受体拮抗剂
|
CN1780621A
(zh)
|
2001-08-03 |
2006-05-31 |
先灵公司 |
作为γ分泌酶抑制剂的磺酰胺衍生物
|
EP1283384A3
(en)
|
2001-08-09 |
2004-08-11 |
Smiths Wolverhampton Limited |
Ballscrew locking nut
|
JP2003081937A
(ja)
|
2001-09-07 |
2003-03-19 |
Bayer Ag |
ベンゼンスルホンアミド誘導体
|
WO2003024451A1
(de)
|
2001-09-08 |
2003-03-27 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
2-(2-phenylethyl)-benzimidazol-5-carboxamid- derivative und ihre verwendung als tryptase_ inhibitoren
|
WO2003024456A1
(en)
|
2001-09-20 |
2003-03-27 |
Eisai Co., Ltd. |
Methods for treating and preventing migraines
|
WO2003028641A2
(en)
|
2001-10-01 |
2003-04-10 |
Taisho Pharmaceutical Co., Ltd. |
Mch receptor antagonists
|
JP4643141B2
(ja)
|
2001-10-25 |
2011-03-02 |
シェーリング コーポレイション |
肥満治療用のmchアンタゴニスト
|
DE60234116D1
(de)
|
2001-11-26 |
2009-12-03 |
Schering Corp |
Piperidin mch antagonisten und ihre verwendung in der behandlung von obesität und störungen des zentralnervensystems
|
CA2837936A1
(en)
|
2001-11-26 |
2003-06-05 |
Trustees Of Tufts College |
Peptidomimetic inhibitors of post-proline cleaving enzymes
|
ATE312090T1
(de)
|
2001-12-04 |
2005-12-15 |
Actelion Pharmaceuticals Ltd |
4-(piperidyl- und pyrrolidyl-alkyl-ureido)- chinoline als urotensin ii rezeptor antagonisten
|
WO2003049736A1
(en)
|
2001-12-11 |
2003-06-19 |
Sepracor, Inc. |
4-substituted piperidines, and methods of use thereof
|
GB0130261D0
(en)
*
|
2001-12-18 |
2002-02-06 |
Pfizer Ltd |
Lactams as tachykinin antagonists
|
DE60236458D1
(de)
|
2001-12-20 |
2010-07-01 |
Osi Pharm Inc |
Pyrrolopyrimidin a2b selektive antagonistische verbindungen, deren synthese und verwendung
|
WO2003059265A2
(en)
*
|
2001-12-21 |
2003-07-24 |
Cytokinetics, Inc. |
Compositions and methods for treating heart failure
|
US6995144B2
(en)
|
2002-03-14 |
2006-02-07 |
Eisai Co., Ltd. |
Nitrogen containing heterocyclic compounds and medicines containing the same
|
JP2005520522A
(ja)
|
2002-03-19 |
2005-07-14 |
ノバルティス アクチエンゲゼルシャフト |
慢性神経痛の抑制に有用な化合物の同定方法およびその組成物
|
US20060069104A1
(en)
|
2002-04-10 |
2006-03-30 |
Toshio Matsuda |
Neurotrophic factor production accelerator
|
DE10217006A1
(de)
|
2002-04-16 |
2003-11-06 |
Merck Patent Gmbh |
Substituierte Indole
|
TW200409637A
(en)
|
2002-06-26 |
2004-06-16 |
Glaxo Group Ltd |
Compounds
|
PE20040749A1
(es)
|
2002-06-27 |
2004-10-23 |
Schering Corp |
Piperidinas espirosustituidas como antagonistas selectivos del receptor de la hormona concentradora de melanina
|
AU2003249983A1
(en)
|
2002-07-18 |
2004-02-09 |
Actelion Pharmaceuticals Ltd |
Piperidines useful for the treatment of central nervous system disorders
|
TW200401635A
(en)
|
2002-07-23 |
2004-02-01 |
Yamanouchi Pharma Co Ltd |
2-Cyano-4-fluoropyrrolidine derivative or salt thereof
|
WO2004019940A1
(en)
|
2002-08-30 |
2004-03-11 |
Pharmacia & Upjohn Company |
Method of preventing or treating atherosclerosis or restenosis
|
DE60335891D1
(de)
|
2002-10-11 |
2011-03-10 |
Actelion Pharmaceuticals Ltd |
Sulphonylaminoessigsaeure derivate und deren verwendung als orexin rezeptor antagoniste
|
SE0203752D0
(sv)
|
2002-12-17 |
2002-12-17 |
Astrazeneca Ab |
New compounds
|
TW200510311A
(en)
|
2002-12-23 |
2005-03-16 |
Millennium Pharm Inc |
CCr8 inhibitors
|
US7491827B2
(en)
|
2002-12-23 |
2009-02-17 |
Millennium Pharmaceuticals, Inc. |
Aryl sulfonamides useful as inhibitors of chemokine receptor activity
|
EP1590327A1
(en)
|
2002-12-23 |
2005-11-02 |
Millennium Pharmaceuticals, Inc. |
Ccr8 inhibitors
|
TW200505834A
(en)
|
2003-03-18 |
2005-02-16 |
Sankyo Co |
Sulfamide derivative and the pharmaceutical composition thereof
|
AR043633A1
(es)
|
2003-03-20 |
2005-08-03 |
Schering Corp |
Ligandos de receptores de canabinoides
|
EP1613322A4
(en)
|
2003-04-11 |
2008-08-13 |
Taigen Biotechnology Co Ltd |
AMINOQUINOLINE COMPOUNDS
|
US7049323B2
(en)
|
2003-04-25 |
2006-05-23 |
Bristol-Myers Squibb Company |
Amidoheterocycles as modulators of the melanocortin-4 receptor
|
US7405210B2
(en)
|
2003-05-21 |
2008-07-29 |
Osi Pharmaceuticals, Inc. |
Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phosphorylase
|
CN1226059C
(zh)
|
2003-05-21 |
2005-11-09 |
江西洪达医疗器械集团有限公司 |
自毁式安全注射器
|
CA2527159A1
(en)
|
2003-05-30 |
2004-12-09 |
Neuromed Technologies, Inc. |
3-aminomethyl-pyrrolidines as n-type calcium channel blockers
|
DE602004022819D1
(de)
|
2003-06-06 |
2009-10-08 |
Vertex Pharma |
Von atp-bindende kassette transportern
|
GB0314054D0
(en)
|
2003-06-17 |
2003-07-23 |
Pfizer Ltd |
Amide derivatives as selective serotonin re-uptake inhibitors
|
WO2005004497A1
(en)
|
2003-07-04 |
2005-01-13 |
Koninklijke Philips Electronics N.V. |
Colour projection systems with improved lifetime
|
GB0317315D0
(en)
|
2003-07-24 |
2003-08-27 |
Astex Technology Ltd |
Pharmaceutical compounds
|
WO2005011693A1
(en)
|
2003-08-01 |
2005-02-10 |
Chugai Seiyaku Kabushiki Kaisha |
Piperidine compounds useful as malonyl-coa decarboxylase inhibitors
|
WO2005030754A1
(en)
|
2003-09-24 |
2005-04-07 |
Janssen Pharmaceutica, N.V. |
Indole or quinoline derivatives as non-pepticid npy y2 receptor inhibitors useful for the treatment of anxiolytic and depressive disorders and obesity
|
EP1663953A1
(en)
|
2003-09-24 |
2006-06-07 |
Methylgene, Inc. |
Inhibitors of histone deacetylase
|
MXPA06003264A
(es)
|
2003-09-26 |
2006-06-08 |
Actelion Pharmaceuticals Ltd |
Derivados de piridina y uso de los mismos como antagonistas de la urotensina ii.
|
US20050119266A1
(en)
|
2003-10-01 |
2005-06-02 |
Yan Shi |
Pyrrolidine and piperidine derivatives as factor Xa inhibitors
|
GB0325956D0
(en)
|
2003-11-06 |
2003-12-10 |
Addex Pharmaceuticals Sa |
Novel compounds
|
GB0326546D0
(en)
|
2003-11-14 |
2003-12-17 |
Amersham Plc |
Inhibitor imaging agents
|
JP3687672B2
(ja)
|
2003-11-25 |
2005-08-24 |
松下電工株式会社 |
粉末焼結部品の表面仕上げ方法
|
JP2005154380A
(ja)
|
2003-11-28 |
2005-06-16 |
Tanabe Seiyaku Co Ltd |
ピペリジン誘導体
|
JP4380508B2
(ja)
|
2003-11-28 |
2009-12-09 |
田辺三菱製薬株式会社 |
医薬組成物
|
TW200530226A
(en)
|
2003-12-03 |
2005-09-16 |
Glaxo Group Ltd |
Novel M3 muscarinic acetylcholine receptor antagonists
|
MXPA06007667A
(es)
|
2004-01-06 |
2006-09-01 |
Novo Nordisk As |
Heteroaril-ureas y su uso como activadores de glucocinasa.
|
US7507760B2
(en)
|
2004-01-22 |
2009-03-24 |
Neuromed Pharmaceuticals Ltd. |
N-type calcium channel blockers
|
US20050197336A1
(en)
|
2004-03-08 |
2005-09-08 |
Miikana Therapeutics Corporation |
Inhibitors of histone deacetylase
|
EP1723102A2
(en)
|
2004-03-11 |
2006-11-22 |
Elan Pharmaceuticals, Inc. |
N-substituted benzene sulfonamides
|
DE102004012070A1
(de)
|
2004-03-12 |
2005-09-29 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue cycloalkyl-haltige 5-Acylindolinone, deren Herstellung und deren Verwendung als Arzneimittel
|
US7217702B2
(en)
|
2004-04-02 |
2007-05-15 |
Adenosine Therapeutics, Llc |
Selective antagonists of A2A adenosine receptors
|
JP4700684B2
(ja)
|
2004-04-02 |
2011-06-15 |
ノバルティス アーゲー |
2型糖尿病の処置に有用なグルコキナーゼアクティベーターとしてのスルホンアミド−チアゾロピリジン誘導体
|
KR20070044803A
(ko)
|
2004-04-09 |
2007-04-30 |
뉴로메드 파머큐티칼즈 리미티드 |
칼슘 채널 차단제로서 디아릴아민 유도체
|
BRPI0509660A
(pt)
|
2004-04-09 |
2007-10-09 |
Millennium Pharm Inc |
compostos de beta-carbolina de utilidade no tratamento de doenças inflamatórias
|
US7880001B2
(en)
|
2004-04-29 |
2011-02-01 |
Abbott Laboratories |
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme
|
ME01942B
(me)
|
2004-06-17 |
2015-05-20 |
Cytokinetics Inc |
Jedinjenja, preparati i metode
|
EP1760073A4
(en)
|
2004-06-24 |
2008-05-21 |
Shionogi & Co |
SULPHONAMIDE COMPOUND
|
JP2008512461A
(ja)
|
2004-09-07 |
2008-04-24 |
スミスクライン・ビーチャム・コーポレイション |
新規化合物
|
TW200621723A
(en)
|
2004-09-09 |
2006-07-01 |
Chugai Pharmaceutical Co Ltd |
Novel imidazolidine derivative and use thereof
|
GB0420424D0
(en)
|
2004-09-14 |
2004-10-20 |
Ionix Pharmaceuticals Ltd |
Therapeutic compounds
|
JP2006083137A
(ja)
|
2004-09-17 |
2006-03-30 |
Sankyo Co Ltd |
免疫抑制剤
|
JP2006083133A
(ja)
|
2004-09-17 |
2006-03-30 |
Sankyo Co Ltd |
スルファミド誘導体医薬組成物
|
TW200630337A
(en)
*
|
2004-10-14 |
2006-09-01 |
Euro Celtique Sa |
Piperidinyl compounds and the use thereof
|
TW200843761A
(en)
|
2004-10-28 |
2008-11-16 |
Shionogi & Co |
3-carbamoyl-2-pyridone derivatives
|
EP1702916A1
(en)
|
2005-03-18 |
2006-09-20 |
Santhera Pharmaceuticals (Schweiz) GmbH |
DPP-IV inhibitors
|
EP1863490A2
(en)
|
2005-03-28 |
2007-12-12 |
Vertex Pharmaceuticals Incorporated |
Muscarinic modulators
|
EP1866298A2
(en)
|
2005-03-31 |
2007-12-19 |
Takeda San Diego, Inc. |
Hydroxysteroid dehydrogenase inhibitors
|
WO2006134481A1
(en)
|
2005-06-16 |
2006-12-21 |
Pfizer Inc. |
Inhibitors of 11-beta hydroxysteroid dehydrogenase type 1
|
WO2007002884A2
(en)
|
2005-06-29 |
2007-01-04 |
Merck & Co., Inc. |
4-fluoro-piperidine t-type calcium channel antagonists
|
WO2007052843A1
(ja)
|
2005-11-04 |
2007-05-10 |
Takeda Pharmaceutical Company Limited |
複素環アミド化合物およびその用途
|
PE20071092A1
(es)
|
2005-12-08 |
2007-12-10 |
Aventis Pharma Inc |
Composicion farmaceutica que comprende un antagonista de cb1 y un agente antisicotico
|
CA2633379A1
(en)
|
2005-12-22 |
2007-07-05 |
Merck & Co., Inc. |
Substituted piperidines as calcium channel blockers
|
US8247442B2
(en)
|
2006-03-29 |
2012-08-21 |
Purdue Pharma L.P. |
Benzenesulfonamide compounds and their use
|
TW200812963A
(en)
|
2006-04-13 |
2008-03-16 |
Euro Celtique Sa |
Benzenesulfonamide compounds and the use thereof
|
WO2007118853A1
(en)
|
2006-04-13 |
2007-10-25 |
Euro-Celtique S.A. |
Benzenesulfonamide compounds and their use as blockers of calcium channels
|
JP2008044009A
(ja)
*
|
2006-07-19 |
2008-02-28 |
Honda Motor Co Ltd |
熱膨張係数が異なる部材の接合方法
|
TW200825072A
(en)
|
2006-10-20 |
2008-06-16 |
Arete Therapeutics Inc |
Soluble epoxide hydrolase inhibitors
|
WO2008050200A1
(en)
|
2006-10-24 |
2008-05-02 |
Pfizer Products Inc. |
Oxadiazole compounds as calcium channel antagonists
|
PE20080932A1
(es)
|
2006-11-10 |
2008-07-13 |
Wyeth Corp |
Piperidinil 4-arilsulfonamidas n-sustituidas como moduladores de la proteina 1 secretada relacionada con frizzled (sfrp-1)
|
AU2008220104B2
(en)
|
2007-02-28 |
2012-09-27 |
Asahi Kasei Pharma Corporation |
Sulfonamide derivative
|
US8399486B2
(en)
|
2007-04-09 |
2013-03-19 |
Purdue Pharma L.P. |
Benzenesulfonyl compounds and the use thereof
|
US8765736B2
(en)
|
2007-09-28 |
2014-07-01 |
Purdue Pharma L.P. |
Benzenesulfonamide compounds and the use thereof
|